123 related articles for article (PubMed ID: 36759425)
1. The role of poly (ADP-ribose) glycohydrolase in phosphatase and tensin homolog deficiency endometrial cancer.
Sun Y; Shi Y; Liu H; Lv C; Zhang A
J Obstet Gynaecol Res; 2023 Apr; 49(4):1244-1254. PubMed ID: 36759425
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) Glycohydrolase deficiency sensitizes mouse ES cells to DNA damaging agents.
Fujihara H; Ogino H; Maeda D; Shirai H; Nozaki T; Kamada N; Jishage K; Tanuma S; Takato T; Ochiya T; Sugimura T; Masutani M
Curr Cancer Drug Targets; 2009 Dec; 9(8):953-62. PubMed ID: 20025604
[TBL] [Abstract][Full Text] [Related]
3. Parg deficiency confers radio-sensitization through enhanced cell death in mouse ES cells exposed to various forms of ionizing radiation.
Shirai H; Fujimori H; Gunji A; Maeda D; Hirai T; Poetsch AR; Harada H; Yoshida T; Sasai K; Okayasu R; Masutani M
Biochem Biophys Res Commun; 2013 May; 435(1):100-6. PubMed ID: 23624507
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents.
Matanes E; López-Ozuna VM; Octeau D; Baloch T; Racovitan F; Dhillon AK; Kessous R; Raban O; Kogan L; Salvador S; Lau S; Gotlieb WH; Yasmeen A
Front Oncol; 2021; 11():745981. PubMed ID: 34778062
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
Feng X; Koh DW
Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
[TBL] [Abstract][Full Text] [Related]
6. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.
Poitras MF; Koh DW; Yu SW; Andrabi SA; Mandir AS; Poirier GG; Dawson VL; Dawson TM
Neuroscience; 2007 Aug; 148(1):198-211. PubMed ID: 17640816
[TBL] [Abstract][Full Text] [Related]
7. Tannic acid, an inhibitor of poly(ADP-ribose) glycohydrolase, sensitizes ovarian carcinoma cells to cisplatin.
Sun Y; Zhang T; Wang B; Li H; Li P
Anticancer Drugs; 2012 Oct; 23(9):979-90. PubMed ID: 22785358
[TBL] [Abstract][Full Text] [Related]
8. PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
Bian X; Gao J; Luo F; Rui C; Zheng T; Wang D; Wang Y; Roberts TM; Liu P; Zhao JJ; Cheng H
Oncogene; 2018 Jan; 37(3):341-351. PubMed ID: 28945226
[TBL] [Abstract][Full Text] [Related]
9. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S
Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708
[TBL] [Abstract][Full Text] [Related]
11. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
[TBL] [Abstract][Full Text] [Related]
12. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
[TBL] [Abstract][Full Text] [Related]
13. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells.
Frizzell KM; Gamble MJ; Berrocal JG; Zhang T; Krishnakumar R; Cen Y; Sauve AA; Kraus WL
J Biol Chem; 2009 Dec; 284(49):33926-38. PubMed ID: 19812418
[TBL] [Abstract][Full Text] [Related]
14. Silencing of poly(ADP-ribose) glycohydrolase sensitizes lung cancer cells to radiation through the abrogation of DNA damage checkpoint.
Nakadate Y; Kodera Y; Kitamura Y; Tachibana T; Tamura T; Koizumi F
Biochem Biophys Res Commun; 2013 Nov; 441(4):793-8. PubMed ID: 24211580
[TBL] [Abstract][Full Text] [Related]
15. PARG Inhibitors and Functional PARG Inhibition Models.
Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
[TBL] [Abstract][Full Text] [Related]
16. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
Zhou Y; Feng X; Koh DW
Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
[TBL] [Abstract][Full Text] [Related]
17. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase.
Slade D; Dunstan MS; Barkauskaite E; Weston R; Lafite P; Dixon N; Ahel M; Leys D; Ahel I
Nature; 2011 Sep; 477(7366):616-20. PubMed ID: 21892188
[TBL] [Abstract][Full Text] [Related]
18. Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis.
Feng X; Koh DW
Int Rev Cell Mol Biol; 2013; 304():227-81. PubMed ID: 23809438
[TBL] [Abstract][Full Text] [Related]
19. Poly (ADP-ribose) glycohydrolase silencing-mediated maintenance of H2A and downregulation of H2AK9me protect human bronchial epithelial cells from benzo(a)pyrene-induced carcinogenesis.
Zeng Z; Liu H; Yuan J; Ren X; Deng Y; Dai W; Wu Y; Huang Y; Huang R; Liu J; Huang H; Hu J
Toxicol Lett; 2018 Oct; 295():270-276. PubMed ID: 29981922
[TBL] [Abstract][Full Text] [Related]
20. Alteration of poly(ADP-ribose) glycohydrolase nucleocytoplasmic shuttling characteristics upon cleavage by apoptotic proteases.
Bonicalzi ME; Vodenicharov M; Coulombe M; Gagné JP; Poirier GG
Biol Cell; 2003 Dec; 95(9):635-44. PubMed ID: 14720466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
